|
IPO7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63882999999476E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.50829999945712E-07 |
| Normal-vs-Stage2 |
6.078100E-02 |
| Normal-vs-Stage3 |
1.834970E-01 |
| Normal-vs-Stage4 |
4.672400E-01 |
| Stage1-vs-Stage2 |
3.656000E-01 |
| Stage1-vs-Stage3 |
5.773600E-02 |
| Stage1-vs-Stage4 |
8.668400E-02 |
| Stage2-vs-Stage3 |
5.457800E-01 |
| Stage2-vs-Stage4 |
3.659000E-01 |
| Stage3-vs-Stage4 |
6.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76029999999772E-05 |
| Normal-vs-AfricanAmerican |
1.797540E-03 |
| Normal-vs-Asian |
1.173020E-01 |
| Caucasian-vs-AfricanAmerican |
7.428200E-01 |
| Caucasian-vs-Asian |
7.673600E-01 |
| AfricanAmerican-vs-Asian |
8.491800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.85310000069927E-08 |
| Normal-vs-Female |
6.365000E-01 |
| Male-vs-Female |
4.195100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.344200E-03 |
| Normal-vs-Extreme_Weight |
4.39920000427918E-08 |
| Normal-vs-Obese |
1.110580E-01 |
| Normal-vs-Extreme_Obese |
1.383350E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.187150E-01 |
| Normal_Weight-vs-Obese |
3.631600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.443600E-01 |
| Extreme_Weight-vs-Obese |
1.268270E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.307800E-01 |
| Obese-vs-Extreme_Obese |
1.451620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.096600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.802600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.41709999956774E-07 |
| Normal-vs-Age(81-100Yrs) |
5.75189999999504E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.113700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.578400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.232500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.106100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.403190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.428200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04760000066528E-08 |
| Normal-VS-Type2 PRCC |
3.660400E-03 |
| Normal-VS-KIRP CIMP |
1.334050E-01 |
| Normal-VS-Unclassified PRCC |
8.542500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.150200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.247700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.003800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.754000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.465600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.800500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63530000002665E-06 |
| Normal-vs-N1 |
7.191000E-01 |
| Normal-vs-N2 |
7.545400E-01 |
| N0-vs-N1 |
1.787720E-02 |
| N0-vs-N2 |
1.619410E-01 |
| N1-vs-N2 |
7.915800E-01 |
|
|
